44 results on '"Wittman, I"'
Search Results
2. 89EMFThe Utility of High Dose Buprenorphine in Producing Prolonged Suppression of Opioid Withdrawal
- Author
-
McCormack, R., Gazzola, M., Shin, S.-M., Wittman, I., Gulati, R., Jahnes, K., Rahnemoon, K., Chitnis, A., Olafsson, S., and Herring, A.
- Published
- 2024
- Full Text
- View/download PDF
3. 5 Generative AI Summaries to Facilitate Emergency Department Handoff
- Author
-
Genes, N., Simon, G., Koziatek, C., Koesmahargyo, V., Mbachu, C., Wiesenfeld, B., Kim, J.G., Woo, K-m, Dahn, C., and Wittman, I.
- Published
- 2024
- Full Text
- View/download PDF
4. Proceedings of the 14th annual conference of INEBRIA
- Author
-
Holloway, A.S., Ferguson, J., Landale, S., Cariola, L., Newbury-Birch, D., Flynn, A., Knight, J.R., Sherritt, L., Harris, S.K., O’Donnell, A.J., Kaner, E., Hanratty, B., Loree, A.M., Yonkers, K.A., Ondersma, S.J., Gilstead-Hayden, K., Martino, S., Adam, A., Schwartz, R.P., Wu, L.-T., Subramaniam, G., Sharma, G., McNeely, J., Berman, A.H., Kolaas, K., Petersén, E., Bendtsen, P., Hedman, E., Linderoth, C., Müssener, U., Sinadinovic, K., Spak, F., Gremyr, I., Thurang, A., Mitchell, A.M., Finnell, D., Savage, C.L., Mahmoud, K.F., Riordan, B.C., Conner, T.S., Flett, J.A.M., Scarf, D., McRee, B., Vendetti, J., Gallucci, K.S., Robaina, K., Clark, B.J., Jones, J., Reed, K.D., Hodapp, R.M., Douglas, I., Burnham, E.L., Aagaard, L., Cook, P.F, Harris, B.R., Yu, J., Wolff, M., Rogers, M., Barbosa, C., Wedehase, B.J., Dunlap, L.J., Mitchell, S.G., Dusek, K.A., Gryczynski, J., Kirk, A.S., Oros, M.T., Hosler, C., O’Grady, K.E., Brown, B.S., Angus, C., Sherborne, S., Gillespie, D., Meier, P., Brennan, A., de Vargas, D., Soares, J., Castelblanco, D., Doran, K.M., Wittman, I., Shelley, D., Rotrosen, J., Gelberg, L., Edelman, E.J., Maisto, S.A., Hansen, N.B., Cutter, C.J., Deng, Y., Dziura, J., Fiellin, L.E., O’Connor, P.G., Bedimo, R., Gibert, C., Marconi, V.C., Rimland, D., Rodriguez-Barradas, M.C., Simberkoff, M.S., Justice, A.C., Bryant, K.J., Fiellin, D.A., Giles, E.L., Coulton, S., Deluca, P., Drummond, C., Howel, D., McColl, E., McGovern, R., Scott, S., Stamp, E., Sumnall, H., Vale, L., Alabani, V., Atkinson, A., Boniface, S., Frankham, J., Gilvarry, E., Hendrie, N., Howe, N., McGeechan, G.J., Ramsey, A., Stanley, G., Clephane, J., Gardiner, D., Holmes, J., Martin, N., Shevills, C., Soutar, M., Chi, F.W., Weisner, C., Ross, T.B., Mertens, J., Sterling, S.A., Shorter, G.W., Heather, N., Bray, J., Cohen, H.A., McPherson, T.L., Adam, C., López-Pelayo, H., Gual, A., Segura-Garcia, L., Colom, J., Ornelas, I.J., Doyle, S., Donovan, D., Duran, B., Torres, V., Gaume, J., Grazioli, V., Fortini, C., Paroz, S., Bertholet, N., Daeppen, J.-B., Satterfield, J.M., Gregorich, S., Alvarado, N.J., Muñoz, R., Kulieva, G., Vijayaraghavan, M., Cunningham, J.A., Díaz, E., Palacio-Vieira, J., Godinho, A., Kushir, V., O’Brien, K.H.M., Aguinaldo, L.D., Sellers, C.M., Spirito, A., Chang, G., Blake-Lamb, T., LaFave, L.R.A., Thies, K.M., Pepin, A.L., Sprangers, K.E., Bradley, M., Jorgensen, S., Catano, N.A., Murray, A.R., Schachter, D., Andersen, R.M., Rey, G.N., Vahidi, M., Rico, M.W., Baumeister, S.E., Johansson, M., Sinadinovic, C., Hermansson, U., Andreasson, S., O’Grady, M.A., Kapoor, S., Akkari, C., Bernal, C., Pappacena, K., Morley, J., Auerbach, M., Neighbors, C.J., Kwon, N., Conigliaro, J., Morgenstern, J., Magill, M., Apodaca, T.R., Borsari, B., Hoadley, A., Scott Tonigan, J., Moyers, T., Fitzgerald, N.M., Schölin, L., Barticevic, N., Zuzulich, S., Poblete, F., Norambuena, P., Sacco, P., Ting, L., Beaulieu, M., Wallace, P.G., Andrews, M., Daley, K., Shenker, D., Gallagher, L., Watson, R., Weaver, T., Bruguera, P., Oliveras, C., Gavotti, C., Barrio, P., Braddick, F., Miquel, L., Suárez, M., Bruguera, C., Brown, R.L., Capell, J.W., Paul Moberg, D., Maslowsky, J., Saunders, L.A., McCormack, R.P., Scheidell, J., Gonzalez, M., Bauroth, S., Liu, W., Lindsay, D.L., Lincoln, P., Hagle, H., Wallhed Finn, S., Hammarberg, A., Andréasson, S., King, S.E., Vargo, R., Kameg, B.N., Acquavita, S.P., Van Loon, R.A., Smith, R., Brehm, B.J., Diers, T., Kim, K., Barker, A., Jones, A.L., Skinner, A.C., Hinman, A., Svikis, D.S., Thacker, C.L., Resnicow, K., Beatty, J.R., Janisse, J., Puder, K., Bakshi, A.-S., Milward, J.M., Kimergard, A., Garnett, C.V., Crane, D., Brown, J., West, R., Michie, S., Rosendahl, I., Andersson, C., Gajecki, M., Blankers, M., Donoghue, K., Lynch, E., Maconochie, I., Phillips, C., Pockett, R., Phillips, T., Patton, R., Russell, I., Strang, J., Stewart, M.T., Quinn, A.E., Brolin, M., Evans, B., Horgan, C.M., Liu, J., McCree, F., Kanovsky, D., Oberlander, T., Zhang, H., Hamlin, B., Saunders, R., Barton, M.B., Scholle, S.H., Santora, P., Bhatt, C., Ahmed, K., Hodgkin, D., Gao, W., Merrick, E.L., Drebing, C.E., Larson, M.J., Sharma, M., Petry, N.M., Saitz, R., Weisner, C.M., Young-Wolff, K.C., Lu, W.Y., Blosnich, J.R., Lehavot, K., Glass, J.E., Williams, E.C., Bensley, K.M., Chan, G., Dombrowski, J., Fortney, J., Rubinsky, A.D., Lapham, G.T., Forray, A., Olmstead, T.A., Gilstad-Hayden, K., Kershaw, T., Dillon, P., Weaver, M.F., Grekin, E.R., Ellis, J.D., and McGoron, L.
- Subjects
lcsh:R5-920 ,lcsh:Social pathology. Social and public welfare. Criminology ,lcsh:Medicine (General) ,Meeting Abstracts ,lcsh:HV1-9960 - Published
- 2017
5. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke
- Author
-
Szolnoki, Z., Havasi, V., Bene, J., Komlósi, K., Szöke, D., Somogyvári, F., Kondacs, A., Szabó, M., Fodor, L., Bodor, A., Gáti, I., Wittman, I., and Melegh, B.
- Published
- 2005
6. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
- Author
-
Holman, Rr, Bethel, Ma, Mentz, Rj, Thompson, Vp, Lokhnygina, Y, Buse, Jb, Chan, Jc, Choi, J, Gustavson, Sm, Iqbal, N, Maggioni, Ap, Marso, Sp, Öhman, P, Pagidipati, Nj, Poulter, N, Ramachandran, A, Zinman, B, Hernandez, Af, EXSCEL Study Group, : Califf RM, Patel, R, George, J, Sourij, H, Wong, Yw, Hannan, K, Sellers, Ma, Gottlieb, P, Lavender, P, Leloudis, D, Meadows, Y, Larson, D, Anderson, H, Elkins, M, Stone, A, Tisch, A, Perkins, L, Sanders, K, Campbell, C, Kennedy, I, Heal, P, Masterson, M, Darbyshire, J, Mumtaz, L, Athwal, R, Ferch, A, Batra, P, Durborow, L, Vincent, J, Woodall, A, Flanagan, T, Katona, B, Reicher, B, Pozzi, E, Oulhaj, A, Coleman, R, Rouleau, Jl, Pocock, Sj, Gorelick, F, Mcmurray, J, Riddle, M, Gagel, R, Collier, T, Markovic, T, Kong, Aps, Hian, Sk, Scott, R, Panelo, A, Yoon, Kh, Sheu, W, Sritara, P, Linong, J, Pan, C, Yong, H, Schernthaner, G, Mathieu, C, Tankova, T, Widimsky, P, Hanefeld, M, Keltai, M, Wainstein, J, del Prato, S, Pirags, V, Jakuboniene, N, Kooy, A, Dziemidok, P, Veresiu, Ia, Dreval, Av, Murin, J, Torello, Al, Sattar, N, Parkhomenko, O, Omar, M, Diaz, R, Lopes, R, Lanas, F, Urina Triana, M, Leiva-Pons, Jl, Aguliera, D, Bergenstal, R, Goodman, S, Yale, Jf, Caterson, I, Weng, J, Hu, D, Junbo, G, Zannad, F, Anoop, M, Ambrish, M, Gallegos, Ja, Green, Jb, Akerblom, A, Alexander, K, Al-Khatib, S, Armaganijan, L, Barros, P, Batit, M, Bernacki, G, Bernandez, S, Bloomfield, G, Clausen, E, De Souza Brito, F, Devore, A, Dombrowski, K, Eapen, Z, Gellad, Z, George, D, Guimaraes, P, Halim, S, Harrison, R, Hawes, J, Hess, C, Hyland, K, Jackson, L, Jones, S, Jordan, D, Katz, M, Kong, D, Koshizaka, M, Lakey, W, Leblanc, T, Leonardi, S, Luo, N, Mahaffey, K, Mandawat, A, Mehta, R, Melloni, C, Morse, M, Pagidpati, N, Patel, C, Patel, K, Pokorney, S, Posvic, T, Rao, M, Roe, M, Shah, B, Tillmann, H, Truffa, A, Zazula, A, Zeitler, E, Sicer, M, Ulla, Mr, Maffei, L, Klyver, Mi, Calella, P, Alvarisqueta, A, De La Fuente RL, Aizenberg, D, Roque, F, Cruciani, A, Frechtel, G, Gelersztein, E, Villarino, A, Mallagray, M, Nardone, L, Zaidman, C, Novaretto, L, Bartolacci, I, de Salvo, M, Delcourt, C, Crimmins, D, Jackson, R, O’Neal, D, Colman, P, Jeffries, W, Mah, Pm, Wittert, G, Proietto, J, Amerena, J, Marks, S, Tan, R, Colquhoun, D, Pieber, T, Drexel, H, Prager, R, Schnack, C, Hoppichler, F, Fasching, P, Francesconi, C, Luger, A, Schoenherr, Hr, Ebenbichler, C, Paulweber, B, Shernthaner, G, Verhaegen, A, Vanuytsel, J, Thissen, Jp, e Silva P, Barros, Gonzaga, C, Borges, J, Hissa, M, Rea, R, Rossi, P, Chacra, A, Eliaschewitz, F, Garbelini, B, Felicio, J, Rassi, N, Rossi, F, Nunes dos Santos, M, e Farias F, Bandeira, Lisboa, H, e Forti A, Costa, Saraiva, Jk, Kovacheva, S, Levterov, G, Sheinkova, G, Ilieva, E, Lyubenova, L, Damyanova, V, Gushterova, V, Mincheva, L, Illiev, D, Ivanov, V, Bobeva, R, Nikitov, Z, Shumkova, R, Lefterov, In, Zaharieva, S, Videva, V, Yakov, A, Cheung, S, Elliott, T, Mehta, P, Ross, S, Sigal, R, Woo, V, Jaffer, S, Kuritsky, R, Bell, A, Dumas, R, Gosselin, G, Robitaille, Y, Greenspoon, A, Lochnan, H, Tytus, R, Leiter, L, Pandey, A, Punthakee, Z, Dube, F, Sigalas, J, Pearce, M, Woodford, T, Paul, P, Bourgeois, R, Conway, R, Mazza, G, Hatheway, R, Misterski, J, Raffo, C, Olivares, C, Godoy, J, Potthoff, S, Santibañez, C, Larenas Yanez GJ, Gu, W, Shen, F, Ma, J, Guo, X, Li, Q, Du, Y, Hu, J, Ji, L, Li, Y, Deng, H, Feng, Y, Liu, L, Mu, Y, Ma, C, Qu, S, Wang, J, Wang, Y, Yuan, Z, Zhang, L, Zhou, S, Yang, T, Dong, Y, Liu, D, Coronel Arroyo, J, Perez Amador, G, Botero Lopes, R, Jaramilo, C, Orozco Linares, A, Cure Cure CA, Hernandez Triana, E, Molina de Salazar DI, Marin, Cr, Jaramilo Gomez CJ, Kellinerova, I, Adamkova, V, Krami, P, Brychta, T, Havelkova, J, Pantikova, K, Schoper, F, Pohl, W, Schumm-Draeger, Pm, Julius, U, Tschöpe, D, Hamann, A, Seissler, J, Schellong, S, Rose, L, Becker, B, Linn, T, Oerter, Em, Strotmann, Hj, Mölle, A, Pfutzner, A, Forst, T, Schäufele, T, Mugge, A, Lehrke, M, Meyer-Pannwitt, U, Mehling, H, Simon-Wagner, I, Schenkenberger, I, Busch, K, Hermes, S, Milek, K, Landers, B, Grueneberg, M, Braun, M, Nothroff, J, Kamke, W, Hergdt, G, Duengen, Hd, Kleinertz, K, Kuesters, D, Boenninghoff, Ah, Appel, Kf, Schaefer, A, Bieler, T, Ozaki, R, Luk, Aoy, Chu, Dw, Cheung-Wong, Mm, Siu, Dc, Yan, Bpy, Kung, K, Wong, Sys, Tsang, Cc, Yeung, Vt, Cheung, Bm, Tse, Hf, Hodi, G, Nagy, K, Lippai, J, Takacs, J, Fulop, T, Gaal, Z, Pauker, Z, Foldesi, I, Simon, J, Oroszan, T, Futo, L, Bezzegh, K, Nagy, A, Vandorfi, G, Kiss, J, Kesmarki, N, Kis, E, Papp, A, Kovacs, A, Szakal, I, Palinkas, A, Czegany, Z, Voros, P, Reiber, I, Kerenyi, Z, Dezso, E, Wittman, I, Penzes, J, Ples, Z, Taller, A, Farago, K, Kis, Jt, Zilahi, Z, Molnar, M, Barkai, L, Mileder, M, Szentpeteri, I, Peterfai, E, Lovasz, O, Mosenzon, O, Minuchin, O, Jaffe, A, Vishlitsky, V, Shimon, I, Bashkin, A, Stern, N, Elias, N, Bental, T, Butnaru, A, Lewis, B, Adawi, F, Nseir, W, Klainman, E, Herskovits, T, Cignarelli, M, Rotella, Cm, Ambrosio, G, Pozzilli, P, Genovese, S, Cavarape, A, Salvioni, A, Sokolova, J, Strautina, I, Teterovska, D, Stalte, V, Pastare, S, Leitane, I, Lagzdina, L, Andersone, I, Eglite, R, Stelmane, I, Levinger, A, Barsiene, L, Sulskiene, M, Varanauskiene, E, Danyte, E, Urbanaviciene, E, Urbanavicius, V, Zabuliene, L, Juskiene, R, Velaviciene, A, Kakariekiene, V, Augusteniene, A, Velickiene, D, Lasiene, J, Dauksiene, D, Caponis, J, Tan, At, Ramanathan, L, Hassan, Mra, Tan, F, Ong, Tk, Foo, Sh, Ghani, Ra, Cheah, Wk, Sanchez Mijangos JH, Cabrera Jardines, R, Barrientos Perez, M, Sauque Reyna, L, Alcocer Gamba MA, Villeda Espinosa, E, Tamez Perez HE, De La Garza Hernandez NE, Lopes, Sm, Ramirez Diaz SP, Reyes Sanchez, R, Márquez-Rodriguez, E, Köse, V, Voors-Pette, C, Oldenburg-Ligtenberg, Pc, van Kempen WW, Cox, K, Hoogendyk, J, Swinkels-Diepenmaat, L, Rojas-Lingan, G, Kentgens, S, Schipperen, S, de Valk HW, Swart, H, van Bemmel, B, Hoogslag, Pam, Diamant, M, Serné, Eh, Hamer, A, Wilson, S, Fisher, N, Dixon, P, Chaudhri, O, Crawford, V, Quinn, D, Nirmalaraj, K, Dunn, P, Gillies, J, Cutfield, R, Krebs, J, Helm, C, Kerr, J, Pryke, J, Ebo, G, Denopol, M, Ang, E, Uy, N, Jimeno, C, Mirasoi, R, Paz Pacheco, E, Custodio, M, Nicodemus, N Jr, Catindig, Ea, Magno, M, Tirador, L, Cylkowska, B, Stasinksa, T, Silwinska, T, Sroka, M, Piepiorka, M, Korzeniak, R, Mirecka, H, Zaluska, R, Pupek-Musialik, D, Homenda, W, Grabowska, A, Okopien, B, Niegowska, J, Pogorzelska, H, Mikolajczyk-Swatko, A, Sikorski, M, Sowinski, D, Tahk, Sj, Kim, Yn, Nam, Cw, Rim, Sj, Kim, Cj, Choi, Km, Lee, Ik, Kim, Ij, Namgung, J, Moon, Kw, Kim, Ks, Oh, Bh, Lee, Wy, Choi, Sh, Kim, Es, Moon, S, Mindrescu, Nm, Aron, G, Graur, M, Hancu, N, Mlitaru, C, Nafornita, V, Szilagyi, I, Popa, Ar, Angelescu, Lm, Negrisanu, Gd, Zaharie, Dg, Culman, Mi, Vacaru, G, Munteanu, M, Constantinescu, S, Tivadar, S, Dreval, A, Barbarash, O, Strongin, L, Dogadin, S, Suplotova, L, Izmozherova, N, Marasaev, V, Khokhlov, A, Repin, A, Turova, E, Bondar, I, Samoylova, Y, Sherenkov, A, Smolenskaya, O, Zrahevskiy, K, Koshelskaya, O, Obrezan, A, Dzupina, A, Stevlik, J, Buganova, I, Pella, D, Vinanska, D, Jascur, J, Micko, K, Sosovec, D, Philippiova, A, Olexa, P, Fedacko, J, Selecky, J, Nicolau, J, Mediavilla Garcia, J, Botella Serrano, M, Lecube, A, Arguelles, I, Sabán, J, Gómez Cerezo, F, Soto, A, Bellido, D, Sucunza Alfonso, N, Vendrell Ortega, J, Alvarez, L, Garcia Puig, J, Angustias Quesada, M, Contreras Gilbert, J, Almeida, Ca, Tinahones, Fj, Garcia Ortiz, L, Gómez Marcos MA, Aomar, I, Fernández Balsells, M, Distiller, L, Padayachee, T, Badat, A, Ebrahim, I, Naiker, P, Ranjith, N, Kelfkens, Y, Makan, H, Mogashoa, S, Fulat, M, Carim-Ganey, N, Coetzee, K, Govender, T, Nortje, H, Wilhase, A, Seedat, S, Gani, M, Ellis, G, Rheeder, P, Wing, J, Blignaut, S, Kaplan, H, Lottering, H, Pillai, P, Louw, C, Coetzer, T, Sheu, Whh, Chen, Jf, Yang, Cy, Tseng, St, Wang, Cy, Lai, Wt, Hung, Yj, Hsieh, Ic, Su, Sl, Pei, D, Benjasuratwong, Y, Purewal, T, Milward, A, Dimitropoulos, I, Kumar, S, Barber, T, Wiles, P, Dang, C, Adler, A, Philip, S, Bellary, S, Price, D, Oelbaum, R, Heller, S, Sathayapalan, T, Clark, J, Leese, G, Simpson, H, Kilvert, A, Dawson, A, Hall, T, Takhar, A, Bundy, C, Harvey, P, Maxwell, S, Asamoah-Owusu, Nj, Mcknight, J, Chatterjee, S, Calvert, J, Wright, A, Macrury, S, Macfarlane, D, Johnson, A, Litchfield, J, Field, B, Koval, O, Larin, O, Levchenko, O, Martynyuk, L, Maslyanko, V, Rudyk, I, Suprun, Y, Tseluyko, V, Botsyurko, V, Vatutin, M, Fushtey, I, Grishyna, O, Kuskalo, P, Panina, S, Pererva, L, Prysupa, L, Teliatnikova, Z, Sokolova, L, Vlasenko, M, Berenfus, V, Gyrina, O, Kopytsya, M, Vizir, V, Vayda, M, Shanik, M, Headapohl, D, Pahl, J, Aronoff, S, Bartkowiak, A Jr, Chang, A, Gaudiani, L, Kayne, D, Look, M, Patel, N, Moran, J, Stout, E, Tsao, J, Struble, R, Fishman, N, Rodbard, H, Lucas, K, Dugano-Daphnis, P, Merrick, B, Nadar, V, Severa, L, Sorli, C, Chang, M, Reed, J III, Grunberger, G, Bain, C, Bestermann, W Jr, Morawski, E, White, J, Azizad, M, Ukwade, P, Anekwe, A, Jimenez, A, Weiss, D, Green, S, Overcash, J, Eaton, C, Roseman, H, Soler, N, Mikell, F, Manos, P, Levinson, L, Claxton, E Jr, Weiss, R, Argoud, G, Bickel, L, Wilson, J, Short, B, Webster, B, Mcneill, R, Schnall, A, Force, R, Phillips, L, Bybee, K, Forker, A, Denham, D, Vonderhaar, T, Pullman, J, Kruger, D, Whitehouse, F, Wysham, C, Baron, M, Kravitz, A, Dushkin, H, Manning, Mb, Wine, A, Jaffrani, N, Chadha, C, Sperl-Hillen, J, Busch, R, Estevez, R, Robbins, D, Rassouli, N, Garvey, T, Oparil, S, Eckel, R, Mcdermott, M, Rasouli, N, Mcgill, J, Corder, C, Klonoff, D, Mills, R, Earl, J, Kessel, J, Cuddihy, R, Zimmerman, R, Dayamani, P, Oral, E, Zimering, M, Marks, J, Farnsworth, K, Sugimoto, D, Toth, P, Bhargava, A, Mcguire, D, Rohatgi, A, Davies, M, Peden, E, Wyne, K, Alfonso, L, Seyoum, B, Akpunonu, B, Feinglos, M, Reaven, P, Soule, J, Luttrell, L, Schactman, B, Canadas, R, Boggs, B, Abbott, L, Herring, C, Roberts, L, Hage-Korban, E, Schubart, U, Taylon, A, Tannenbaum, A, Kingsley, J, Lenhard, J, Biscoveanu, M, Cohen, J, Donovan, D, Laferrere, B, Thompson, N, Wade, T, Detweiler, R, Henson, B, White, A, Cavale, A, Ravi, C, Thomas, A, Goodman, H, Kalen, V, Fox, D, Dauber, I, Rizvi, S, Marcus, A, Mulford, M, Higgins, A, Chane, M, Bland, V, Osunkoya, A, Suresh, D, Khan, S, Anastasi, L, Bajaj, M, Eisen, H, Mudaliar, Sr, Powell, S, Carr, K, Tripathy, D, Azad, N, Wakefield, P, Acheatel, R, Bressler, P, Dean, J, El Shahawy, M, Gilbert, J, Haque, I, Humiston, D, Ison, R, Karounos, D, Lillestol, M, Ferrier, N, Labroo, A, Vo, A, D’Agostino, R, Dulin, M, Mcwilliams, A, Hargrove, J, Blumberg, E, Jackson, B, Staniloae, C, Salacata, A, Hidalgo, H Jr, Nicol, P, Digiovanna, M, Soufer, J, Mahabadi, V, Akinboboye, O, Arauz-Pacheco, C, Neutel, J, Dungan, K, Benson, M, Powell, T, Gandy, W, Rovner, S, Berk, M, Khan, A, Ledesma, G, Madu, I, Erickson, B, Radbill, M, Graves, M, Kaczmarek, G, Giep, S, Baldauf, C, Golden, G, Lesh, K, Davis, C, Godbole, N, Kirby, W, Razzaque, N, Bhatt, B, Wilson, M., Internal medicine, ACS - Diabetes & metabolism, and ACS - Microcirculation
- Subjects
Male ,medicine.medical_specialty ,EXSCEL Study Group ,Injections, Subcutaneous ,030209 endocrinology & metabolism ,Type 2 diabetes ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Placebo ,Article ,Drug Administration Schedule ,GLP1-agonists ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Interquartile range ,Internal medicine ,Diabetes mellitus ,General & Internal Medicine ,medicine ,Humans ,Hypoglycemic Agents ,Least-Squares Analysis ,Aged ,Glycated Hemoglobin ,business.industry ,Venoms ,Semaglutide ,Incidence ,Type 2 diabetes, GLP1-agonists, exenatide, cardiovascular effects ,General Medicine ,11 Medical And Health Sciences ,Middle Aged ,medicine.disease ,Surgery ,Albiglutide ,Editorial ,Diabetes Mellitus, Type 2 ,Cardiovascular Diseases ,Exenatide ,Dulaglutide ,Female ,business ,Peptides ,cardiovascular effects ,medicine.drug - Abstract
BACKGROUND: The cardiovascular effects of adding once-weekly treatment with exenatide to usual care in patients with type 2 diabetes are unknown. METHODS: We randomly assigned patients with type 2 diabetes, with or without previous cardiovascular disease, to receive subcutaneous injections of extended-release exenatide at a dose of 2 mg or matching placebo once weekly. The primary composite outcome was the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The coprimary hypotheses were that exenatide, administered once weekly, would be noninferior to placebo with respect to safety and superior to placebo with respect to efficacy. RESULTS: In all, 14,752 patients (of whom 10,782 [73.1%] had previous cardiovascular disease) were followed for a median of 3.2 years (interquartile range, 2.2 to 4.4). A primary composite outcome event occurred in 839 of 7356 patients (11.4%; 3.7 events per 100 person-years) in the exenatide group and in 905 of 7396 patients (12.2%; 4.0 events per 100 person-years) in the placebo group (hazard ratio, 0.91; 95% confidence interval [CI], 0.83 to 1.00), with the intention-to-treat analysis indicating that exenatide, administered once weekly, was noninferior to placebo with respect to safety (P
- Published
- 2017
- Full Text
- View/download PDF
7. Untersuchungen über Leukocytose: III. Wirkung der Acetonkörper auf das weiße Blutbild
- Author
-
Gottsegen, G. and Wittman, I.
- Published
- 1936
- Full Text
- View/download PDF
8. �ber Ver�nderungen der elektrischen Gehirnaktivit�t beim Menschen nach mechanischer D�nndarmreizung
- Author
-
Preisich, P., primary, Wittman, I., additional, A�d�m, G., additional, and Kelemen, V., additional
- Full Text
- View/download PDF
9. Diagnostic Relation Between Gastroscopical and Roentgenological Examinations on the Basis of 2200 Cases
- Author
-
Wittman, I., primary, To�th, E., additional, and Trebitsch, M., additional
- Full Text
- View/download PDF
10. Untersuchungen über Leukocytose.
- Author
-
Gottsegen, G. and Wittman, I.
- Abstract
Copyright of Zeitschrift Für Die Gesamte Experimentelle Medizin is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 1936
- Full Text
- View/download PDF
11. PERITONEOSCPY, VOLUMES 1 AND 2
- Author
-
Wittman, I., primary
- Published
- 1966
- Full Text
- View/download PDF
12. Prevention and treatment of diabetic nephropathy.
- Author
-
Wittman I, Molnár GA, Degrell P, Wagner Z, Tamaskó M, Laczy B, Brasnyó P, Wagner L, and Nagy J
- Abstract
Increasing number of diabetic patients develop different stages of renal failure. However, often an inappropriate parameter, the serum creatinine is measured as a marker of glomerular function. Calculated glomerular filtration rate or endogenous creatinine clearance are suggested to be used for the estimation of the glomerular function. Important structures preventing proteinuria in the kidney are glomerular basement membrane, podocytes and proximal tubular cells. In diabetes mellitus loss of nephrin of podocytes can play a role in the development of microalbuminuria, and podocyte desquamation may result in the progression to proteinuria. In diabetes mellitus there is an increased formation of advanced glycation endproducts (AGE), of which the only elimination organ is the kidney. The AGE induce proteinuria and atherosclerosis. Therefore, in diabetes mellitus a vicious circle develops due to proteinuria, nephron loss and accumulation of AGE, which play a role in the initiation and progression of diabetic nephropathy and atherosclerosis. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers having antiproteinuric effect may decrease the risk of diabetic nephropathy and atherosclerosis. Improvement of carbohydrate metabolism with a consequential decrease in the formation of AGE is an important contributor to the prevention and treatment of diabetic nephropathy and atherosclerosis. [ABSTRACT FROM AUTHOR]
- Published
- 2005
13. Implementation of a peer-delivered opioid overdose response initiative in New York City emergency departments: Insight from multi-stakeholder qualitative interviews.
- Author
-
Goldberg LA, Chang TE, Freeman R, Welch AE, Jeffers A, Kepler KL, Chambless D, Wittman I, Cowan E, Shelley D, McNeely J, and Doran KM
- Abstract
Background: Emergency departments (EDs) are critical touchpoints for overdose prevention efforts. In New York City (NYC), the Health Department's Relay initiative dispatches trained peer "Wellness Advocates" (WAs) to engage with patients in EDs after an overdose and for up to 90 days subsequently. Interest in peer-delivered interventions for patients at risk for overdose has grown nationally, but few studies have explored challenges and opportunities related to implementing such interventions in EDs., Methods: We conducted in-depth interviews with Relay WAs, ED patients, and ED providers across 4 diverse NYC EDs. Sampling was purposeful and continued until theoretical saturation was reached. Interviews followed a semi-structured interview guide based on key domains from the Consolidated Framework for Implementation Research (CFIR). Interviews were conducted by telephone or web conferencing; audio recordings were professionally transcribed. The study utilized rapid qualitative analysis using template summaries and summary matrices followed by line-by-line coding conducted independently by 3 researchers, then discussed and harmonized at group coding meetings. Coding was both inductive (using an a priori code list based on CFIR domains and study goals) and deductive (new codes allowed to emerge from transcripts). Dedoose software was used for data organization., Results: We conducted 32 in-depth interviews (10 WAs, 12 patients, 10 ED providers). Four overarching themes emerged: 1) EDs are characterized by multiple competing demands (e.g., related to provider time and physical space), underscoring the utility of Relay and leading to some practical challenges for its delivery; 2) There is a strong role distinction of WAs as peers with lived experience; 3) ED providers value Relay, even though they have a limited understanding of its full scope and outcomes; 4) While the role of structural factors (e.g., homelessness and unstable housing) is recognized, responsibility is often placed on patients for controlling their own success., Conclusions: We identified four themes that shed new light on the implementation of peer-based overdose prevention programs in EDs. Our findings highlight unique ED inner and outer setting factors that may impact program implementation and effectiveness. The findings provide actionable information to inform implementation of similar programs nationally., Competing Interests: Declaration of competing interest AEW, AJ, KLK, and DC are employed by the NYC Department of Health and Mental Hygiene, and are or were involved in operation of the Relay initiative. The authors do not report any other competing interests., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Piloting a novel medical student virtual discharge counseling process in the time of the COVID-19 pandemic.
- Author
-
Leybov V, Ross J, Smith SW, Ciardiello A, Maheshwari S, Caspers C, Wittman I, Kuhner C, Stark S, and Conroy N
- Subjects
- Humans, Female, Male, Pilot Projects, Adult, SARS-CoV-2, Emergency Service, Hospital organization & administration, Middle Aged, Telemedicine, Counseling methods, Pandemics, Aged, Distance Counseling methods, COVID-19 epidemiology, Students, Medical psychology, Patient Discharge
- Abstract
Background: During the COVID-19 pandemic, we identified a gap in adequate discharge counseling for COVID-19 patients in the Emergency Department. This was due to high patient volumes and lack of patient education regarding a novel disease. Medical students were also restricted from clinical areas due to safety concerns, compromising their clinical experience. We piloted a novel program in which medical students served as virtual discharge counselors for COVID-19 patients via teleconference. We aimed to demonstrate an impact on patient care by examining the patient bounce back rate as well as assessing medical student education and experience., Methods: This program was piloted in a tertiary care Emergency Department. Medical student volunteers served as virtual discharge counselors. Students were trained in discharge counseling with a standardized protocol and a discharge script. Eligible patients for virtual discharge counseling were 18 years old or greater with a diagnosis of confirmed or suspected COVID-19 and no impediment precluding them from participating in a telemedicine encounter. Counseling was provided via secure teleconference in the patient's preferred language. Counseling included diagnosis, supportive care with medication dosing, quarantine instructions, return precautions, follow up, and time to ask questions. Duration of counseling was recorded and medical students were anonymously surveyed regarding their experience., Results: Over an 18-week period, 45 patients were counseled for a median of 20 min. The 72-hr ED revisit rate was 0%, versus 4.2% in similarly-matched, not counseled COVID-19 patients. 90% of medical students believed this project increased their confidence when speaking with patients while 80% indicated this was their first telemedicine experience., Conclusion: Our pilot discharge program provided patients with an extensive discharge counseling experience that would not otherwise be possible in an urban ED setting and demonstrated benefit to patient care. Medical students received a safe clinical experience that improved their communication skills., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
15. Study protocol for a multisite randomized controlled trial of a peer navigator intervention for emergency department patients with nonfatal opioid overdose.
- Author
-
Doran KM, Welch AE, Jeffers A, Kepler KL, Chambless D, Cowan E, Wittman I, Regina A, Chang TE, Parraga S, Tapia J, Diaz C, Gwadz M, Cleland CM, and McNeely J
- Subjects
- Humans, Analgesics, Opioid therapeutic use, Emergency Service, Hospital, Pandemics, Randomized Controlled Trials as Topic, Multicenter Studies as Topic, COVID-19, Drug Overdose prevention & control, Opiate Overdose drug therapy, Opioid-Related Disorders drug therapy
- Abstract
Background: Patients presenting to emergency departments (EDs) after a nonfatal opioid-involved overdose are at high risk for future overdose and death. Responding to this risk, the New York City (NYC) Department of Health and Mental Hygiene operates the Relay initiative, which dispatches trained peer "Wellness Advocates" to meet patients in the ED after a suspected opioid-involved overdose and follow them for up to 90 days to provide support, education, referrals to treatment, and other resources using a harm reduction framework., Methods: In this article, we describe the protocol for a multisite randomized controlled trial of Relay. Study participants are recruited from four NYC EDs and are randomized to receive the Relay intervention or site-directed care (the control arm). Outcomes are assessed through survey questionnaires conducted at 1-, 3-, and 6-months after the baseline visit, as well as through administrative health data. The primary outcome is the number of opioid-related adverse events, including any opioid-involved overdose or any other substance use-related ED visit, in the 12 months post-baseline. Secondary and exploratory outcomes will also be analyzed, as well as hypothesized mediators and moderators of Relay program effectiveness., Conclusion: We present the protocol for a multisite randomized controlled trial of a peer-delivered OD prevention intervention in EDs. We describe how the study was designed to minimize disruption to routine ED operations, and how the study was implemented and adapted during the COVID-19 pandemic. This trial is registered with ClinicalTrials.gov [NCT04317053]., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
16. Use of a Nerve Agent Antidote-Dosing Tool for Mass Casualty Incident Emergency Preparedness.
- Author
-
Wassner C, Creary K, Miele J, Flynn C, and Wittman I
- Subjects
- Humans, Antidotes, Emergency Service, Hospital, Civil Defense, Mass Casualty Incidents, Nerve Agents, Disaster Planning
- Abstract
Objective: Nerve agent attacks pose a serious threat worldwide and ensuring optimal readiness is essential to management. We review a mass casualty incident (MCI) drill in a busy urban New York City Emergency Department incorporating an antidote-dosing tool., Methods: Emergency Management and Preparedness planned an MCI drill involving a nerve agent exposure and engaged the pharmacy department to participate on a more comprehensive level. The clinical pharmacist prepared a treatment tool with antidote dosing recommendations to distribute to team members participating in the drill., Results: During the launch of the exercise, all clinicians involved reviewed the antidote-dosing tool with the pharmacy team members. Because of the ease of use, limited time was necessary to review the dosing tool before the start of the exercise. After the exercise, feedback regarding the use of the tool was very positive and participants appreciated the tool for use in a theoretical emergency that they have had limited experience managing., Conclusions: Optimizing team preparedness with accessible and practical dosing tools may be a helpful addition to emergency preparedness for chemical and biological events with the potential for many casualties.
- Published
- 2023
- Full Text
- View/download PDF
17. Health-Related Social Needs Among Emergency Department Patients with HIV.
- Author
-
Gerber E, Gelberg L, Cowan E, Mijanovich T, Shelley D, Gulati R, Wittman I, and Doran KM
- Subjects
- Emergency Service, Hospital, Humans, Social Problems, Surveys and Questionnaires, HIV Infections epidemiology, Ill-Housed Persons
- Abstract
Little research has examined the health-related social needs of emergency department (ED) patients who have HIV. We surveyed a random sample of public hospital ED patients and compared the social needs of patients with and without HIV. Social needs were high among all ED patients, but patients with HIV reported significantly higher levels of food insecurity (65.0% vs. 50.3%, p = 0.01) and homelessness or living doubled up (33.8% vs. 21.0%, p < 0.01) than other patients. Our findings suggest the importance of assessing social needs in ED-based interventions for patients with HIV.
- Published
- 2021
- Full Text
- View/download PDF
18. Homeless Shelter Entry in the Year After an Emergency Department Visit: Results From a Linked Data Analysis.
- Author
-
Doran KM, Johns E, Schretzman M, Zuiderveen S, Shinn M, Gulati R, Wittman I, Culhane D, Shelley D, and Mijanovich T
- Subjects
- Adult, Data Management methods, Emergency Service, Hospital organization & administration, Female, Geographic Mapping, Hospitals, Public organization & administration, Hospitals, Public statistics & numerical data, Housing standards, Housing statistics & numerical data, Humans, Male, Middle Aged, New York City, Prevalence, Surveys and Questionnaires, Urban Population statistics & numerical data, Emergency Service, Hospital statistics & numerical data, Ill-Housed Persons statistics & numerical data
- Abstract
Study Objective: Housing instability is prevalent among emergency department (ED) patients and is known to adversely affect health. We aim to determine the incidence and timing of homeless shelter entry after an ED visit among patients who are not currently homeless., Methods: We conducted a random-sample survey of ED patients at an urban public hospital from November 2016 to September 2017. Patients provided identifying information and gave informed consent for us to link their survey data with the New York City Department of Homeless Services shelter database. Shelter use was followed prospectively for 12 months after the baseline ED visit. We examined timing of shelter entry in the 12 months after the ED visit, excluding patients who were homeless at baseline., Results: Of 1,929 unique study participants who were not currently homeless, 96 (5.0%) entered a shelter within 12 months of their baseline ED visit. Much of the shelter entry occurred in the first month after the ED visit, with continued yet slower rates of entry in subsequent months. Patients in our sample who entered a shelter were predominantly men and non-Hispanic black, and commonly had past shelter and frequent ED use., Conclusion: In this single-center study, 5.0% of urban ED patients who were not currently homeless entered a homeless shelter within the year after their ED visit. Particularly if replicated elsewhere, this finding suggests that ED patients may benefit from efforts to identify housing instability and direct them to homelessness prevention programs., (Copyright © 2020 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
19. Acute stroke care in a New York City comprehensive stroke center during the COVID-19 pandemic.
- Author
-
Agarwal S, Scher E, Rossan-Raghunath N, Marolia D, Butnar M, Torres J, Zhang C, Kim S, Sanger M, Humbert K, Tanweer O, Shapiro M, Raz E, Nossek E, Nelson PK, Riina HA, de Havenon A, Wachs M, Farkas J, Tiwari A, Arcot K, Parella DT, Liff J, Wu T, Wittman I, Caldwell R, Frontera J, Lord A, Ishida K, and Yaghi S
- Subjects
- Aged, Aged, 80 and over, COVID-19, Coronavirus Infections diagnosis, Coronavirus Infections epidemiology, Coronavirus Infections virology, Critical Pathways organization & administration, Female, Humans, Male, Middle Aged, New York City epidemiology, Pandemics, Patient Care Team organization & administration, Pneumonia, Viral diagnosis, Pneumonia, Viral epidemiology, Pneumonia, Viral virology, Registries, Retrospective Studies, SARS-CoV-2, Stroke diagnosis, Stroke epidemiology, Time Factors, Time-to-Treatment organization & administration, Treatment Outcome, Workflow, Betacoronavirus pathogenicity, Comprehensive Health Care organization & administration, Coronavirus Infections therapy, Delivery of Health Care, Integrated organization & administration, Pneumonia, Viral therapy, Quality Improvement organization & administration, Quality Indicators, Health Care organization & administration, Stroke therapy, Thrombectomy, Thrombolytic Therapy
- Abstract
Background and Purpose: The coronavirus disease-2019 (COVID-19) pandemic caused unprecedented demand and burden on emergency health care services in New York City. We aim to describe our experience providing acute stroke care at a comprehensive stroke center (CSC) and the impact of the pandemic on the quality of care for patients presenting with acute ischemic stroke (AIS)., Methods: We retrospectively analyzed data from a quality improvement registry of consecutive AIS patients at New York University Langone Health's CSC between 06/01/2019-05/15/2020. During the early stages of the pandemic, the acute stroke process was modified to incorporate COVID-19 screening, testing, and other precautionary measures. We compared stroke quality metrics including treatment times and discharge outcomes of AIS patients during the pandemic (03/012020-05/152020) compared with a historical pre-pandemic group (6/1/2019-2/29/2020)., Results: A total of 754 patients (pandemic-120; pre-pandemic-634) were admitted with a principal diagnosis of AIS; 198 (26.3%) received alteplase and/or mechanical thrombectomy. Despite longer median door to head CT times (16 vs 12 minutes; p = 0.05) and a trend towards longer door to groin puncture times (79.5 vs. 71 min, p = 0.06), the time to alteplase administration (36 vs 35 min; p = 0.83), door to reperfusion times (103 vs 97 min, p = 0.18) and defect-free care (95.2% vs 94.7%; p = 0.84) were similar in the pandemic and pre-pandemic groups. Successful recanalization rates (TICI≥2b) were also similar (82.6% vs. 86.7%, p = 0.48). After adjusting for stroke severity, age and a prior history of transient ischemic attack/stroke, pandemic patients had increased discharge mortality (adjusted OR 2.90 95% CI 1.77 - 7.17, p = 0.021) CONCLUSION: Despite unprecedented demands on emergency healthcare services, early multidisciplinary efforts to adapt the acute stroke treatment process resulted in keeping the stroke quality time metrics close to pre-pandemic levels. Future studies will be needed with a larger cohort comparing discharge and long-term outcomes between pre-pandemic and pandemic AIS patients., Competing Interests: Declaration of Competing Interest None., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
20. Capacity? Informed Consent; Informed Discharge? Uncertainty!
- Author
-
Goldfrank LR and Wittman I
- Subjects
- Humans, Patient Discharge, Uncertainty, Informed Consent, Mental Competency
- Published
- 2017
- Full Text
- View/download PDF
21. [Leptin and glucose metabolism in eating disorders].
- Author
-
Gáti A, Pászthy B, Wittman I, Abrahám I, Jeges S, and Túry F
- Subjects
- Adult, Anorexia Nervosa blood, Body Mass Index, Bulimia Nervosa blood, C-Peptide blood, Case-Control Studies, Female, Glucose Tolerance Test, Humans, Insulin blood, Male, Middle Aged, Radioimmunoassay, Spectrometry, Fluorescence, Blood Glucose metabolism, Feeding and Eating Disorders blood, Leptin blood
- Abstract
Aim: Leptin, which was discovered only a decade ago, is a peptide that informs hypothalamic areas about the energy balance of the body. New research findings, has suggested a possible role of leptin in eating disorders as well. Few data are available about the relationship between leptin, insulin and glucose metabolism in the pathomechanism of eating disorders. The authors were searching for answers to these relationships in their investigations., Methods: The study groups included 56 patients with eating disorders and 22 healthy subjects served as controls. The diagnosis was based on DSM-IV criteria. For measuring leptin, insulin and C-peptide serum concentrations a radioimmunoassay method was applied, and serum glucose concentrations were detected by spectrofluorimetry. Detailed statistical analysis of the results was carried out., Results: A correlation between BMI and serum leptin concentration could be proved only in anorectic patients. In contrast to former findings, there was no correlation between BMI and leptin concentration in the bulimia group, and the leptin concentrations were significantly higher in bulimic patients than in the control group. During the glucose tolerance test, leptin levels showed a significant decrease in the anorexia group., Conclusion: The results raise the possibility of a direct effect of central regulatory mechanisms of food intake in the pathomechanism of anorexia nervosa.
- Published
- 2007
22. Special forms of initial gastric cancer.
- Author
-
Szentirmay Z and Wittman I
- Subjects
- Adenocarcinoma pathology, Adenocarcinoma, Mucinous pathology, Adult, Aged, Carcinoma in Situ pathology, Female, Gastric Mucosa pathology, Humans, Male, Middle Aged, Stomach Diseases complications, Stomach Neoplasms complications, Stomach Neoplasms pathology
- Abstract
1. Fifty-five microscopic cancer foci from 11 gastric resection preparations have been examined. Each focus than 5 mm was less in diameter. They occurred mostly in regions showing chronic atrophic gastritis, less frequently in the margin of peptic ulcer or in a polyp located in the antrum along the lesser curve. The lesions were discovered at routine histologic examination of stomachs operated upon for other primary diseases. 2. Histologically differentiated and undifferentiated types could be distinguished. They were: well differentiated adenocarcinoma, tubular adenocarcinoma, "intraluminal papillary proliferation of the glandular neck", "glandular neck displasia" mucocellular and muconodular carcinoma, and carcinoma in situ. In some cases, different histologic types within the same focus, or more foci of diverse structure in the same patient could be observed. 3. A malignant process developing from the glandular neck region or the surface epithelium could be demonstrated in each type of initial cancer.
- Published
- 1976
23. [Diagnosis and prognosis of esophageal carcinoma].
- Author
-
Wittman I, Horànszki F, Làxzlò P, Nògràdi E, and Toòth E
- Subjects
- Adult, Age Factors, Aged, Biopsy, Cardia pathology, Diverticulum, Esophageal complications, Esophageal Neoplasms radiotherapy, Esophageal Neoplasms surgery, Esophagoscopy, Esophagus pathology, False Negative Reactions, Female, Humans, Male, Middle Aged, Postoperative Complications, Prognosis, Time Factors, Esophageal Neoplasms diagnosis
- Published
- 1974
24. [Interlumen duodenal diverticulum (author's transl)].
- Author
-
Balogh I, Hajdu I, Sawinsky I, Tooth E, and Wittman I
- Subjects
- Humans, Male, Middle Aged, Radiography, Diverticulum diagnostic imaging, Duodenal Diseases diagnostic imaging
- Published
- 1975
25. [Statistical data and problems of organization in gastroenterologic endoscopy in Hungary].
- Author
-
Wittman I, Bodó M, and Lendvai I
- Subjects
- Gastroscopes, Humans, Hungary, Statistics as Topic, Diagnostic Services organization & administration, Gastroscopy
- Published
- 1978
26. [Giant gastric ulcer in old age].
- Author
-
Balogh I, Toóth E, Csillag A, Loczka B, Székely M, and Wittman I
- Subjects
- Age Factors, Aged, Female, Gastrectomy, Gastroscopy, Humans, Hungary, Male, Middle Aged, Statistics as Topic, Stomach Ulcer diagnosis, Stomach Ulcer surgery, Stomach Ulcer epidemiology
- Published
- 1979
27. [Enzyme studies in the healthy and pathologic gastric mucosa].
- Author
-
Kralovánszky J, Szentirmay Z, Wittman I, Toóth E, Huoránszky F, and Eckhardt S
- Subjects
- Humans, Isoenzymes, Acid Phosphatase analysis, Alkaline Phosphatase analysis, Gastric Mucosa enzymology, Gastritis enzymology, Glucuronidase analysis, L-Lactate Dehydrogenase analysis
- Published
- 1974
28. [The role of "urgent endoscopy" in the diagnosis of severe hemorrhages from the upper gastrointestinal tract].
- Author
-
Toóth E, Wittman I, Huoránszki F, Nógrádi E, and Lászlo P
- Subjects
- Diagnosis, Differential, Emergencies, Gastrointestinal Diseases diagnosis, Gastrointestinal Hemorrhage etiology, Gastrointestinal Neoplasms diagnosis, Humans, Esophagoscopy, Gastrointestinal Hemorrhage diagnosis, Gastroscopy
- Published
- 1976
29. [Gastrointestinal polypectomy].
- Author
-
Wittman I
- Subjects
- Colonic Neoplasms surgery, Endoscopy methods, Esophagoscopy methods, Gastroscopy methods, Humans, Rectal Neoplasms surgery, Sigmoid Neoplasms surgery, Gastrointestinal Neoplasms surgery, Intestinal Polyps surgery
- Published
- 1976
30. [Incidence of side effects of gastroenterologic endoscopic examinations in Hungary].
- Author
-
Wittman I and Bodó M
- Subjects
- Humans, Hungary, Statistics as Topic, Endoscopy adverse effects, Gastrointestinal Diseases diagnosis
- Published
- 1981
31. [Experience with chromodiagnostics in liver disease, using the indocyanine green test(author's transl)].
- Author
-
Wittman I, Jakub M, and Huoranszki F
- Subjects
- Humans, Liver Function Tests, Dye Dilution Technique, Indocyanine Green, Liver Diseases diagnosis
- Published
- 1974
32. [Intraluminal duodenal diverticulum causing differential diagnostic problems].
- Author
-
Balogh I, Hajdú I, Sawinsky I, Toóth E, and Wittman I
- Subjects
- Diagnosis, Differential, Diverticulum complications, Duodenal Diseases diagnostic imaging, Duodenal Ulcer complications, Gastroscopy, Humans, Middle Aged, Radiography, Diverticulum diagnosis, Duodenal Diseases diagnosis
- Published
- 1974
33. [RECENT USE OF DYE SOLUTIONS IN DIAGNOSIS. I. CHROMOLAPAROSCOPY. (PRELIMINARY REPORT)].
- Author
-
WITTMAN I, ASZODI Z, and PAPP L
- Subjects
- Acridines, Chlortetracycline, Clinical Laboratory Techniques, Congo Red, Dogs, Endoscopy, Fluoresceins, Fluorescent Dyes, Methylene Blue, Neoplasms diagnosis, Research
- Published
- 1964
34. [Diagnostic role of laparoscopy in diseases of the pancreas].
- Author
-
WITTMAN I
- Subjects
- Humans, Disease, Laparoscopy, Pancreas, Pancreatic Diseases
- Published
- 1961
35. [DRUG THERAPY OF COLITIS ULCEROSA (GRAVIS)].
- Author
-
WITTMAN I and PREISICH P
- Subjects
- Humans, Sulfanilamide, Sulfanilamides, Adrenocorticotropic Hormone, Colitis, Colitis, Ulcerative, Enema, Gastrointestinal Hemorrhage, Prednisolone, Proctoscopy, Steroids, Sulfasalazine, Sulfonamides, Surgical Procedures, Operative
- Published
- 1964
36. [Laparoscopic study of the absorption of dyes administered by intravenous, intra-abdominal and intrasplenic route. (Chromolaparoscopy II)].
- Author
-
Wittman I, Aszódi Z, and Papp L
- Subjects
- Animals, Dogs, Injections, Intraperitoneal, Injections, Intravenous, Fluorescent Dyes, Laparoscopy
- Published
- 1966
37. [Studies on liver diseases using the indocyanine green test].
- Author
-
Huoranszki F, Jakab M, Wittman I, Aszódi Z, and Rendes E
- Subjects
- Alkaline Phosphatase blood, Bilirubin blood, Cholestasis diagnosis, Clinical Enzyme Tests, Fatty Liver diagnosis, Half-Life, Hepatitis diagnosis, Humans, Liver Cirrhosis diagnosis, Liver Diseases enzymology, Liver Function Tests, Liver Neoplasms diagnosis, Methods, Neoplasm Metastasis, Indocyanine Green adverse effects, Liver Diseases diagnosis
- Published
- 1972
38. [Gastrocytologic studies in the recognition of gastric cancer].
- Author
-
Miczbán I, Trebitsch M, and Wittman I
- Subjects
- Gastric Lavage, Gastric Mucosa cytology, Gastroscopy, Humans, Methods, Cytodiagnosis, Stomach Neoplasms diagnosis
- Published
- 1968
39. [Indications and contraindications for laparoscopy].
- Author
-
WITTMAN I
- Subjects
- Humans, Endoscopy, Laparoscopy
- Published
- 1960
40. [The role of the general practitioner in the treatment of ulcerative colitis].
- Author
-
Wittman I
- Subjects
- Humans, Prednisolone therapeutic use, Sulfasalazine therapeutic use, Therapeutic Irrigation, Colitis, Ulcerative therapy
- Published
- 1969
41. [Practical value of endoscopic examinations in gastroenterology].
- Author
-
Wittman I
- Subjects
- Humans, Esophagoscopy, Gastrointestinal Diseases diagnosis, Gastroscopy
- Published
- 1970
42. [Diagnosis and prognosis of fatty liver].
- Author
-
Wittman I and Trebitsch M
- Subjects
- Bilirubin blood, Biopsy, Fatty Liver blood, Fatty Liver drug therapy, Fatty Liver etiology, Fatty Liver pathology, Humans, Liver Cirrhosis pathology, Prognosis, Sulfobromophthalein blood, Fatty Liver diagnosis
- Published
- 1967
43. [Drug therapy of ulcerative colitis].
- Author
-
Wittman I
- Subjects
- Adolescent, Adult, Female, Humans, Male, Middle Aged, Pyridines therapeutic use, Salicylates therapeutic use, Adrenal Cortex Hormones therapeutic use, Colitis, Ulcerative drug therapy, Sulfonamides therapeutic use
- Published
- 1965
44. [On the diagnostic value of the fluorescence phenomenon in endoscopy].
- Author
-
Wittman I
- Subjects
- Diagnosis, Differential, Gastroscopy, Humans, Laparotomy, Methods, Ultraviolet Rays, Endoscopes, Fluorescent Dyes, Neoplasms diagnosis
- Published
- 1968
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.